John Raymond Murphy, Director at Cadrenal Therapeutics, Inc. (CVKD), bought 10,000 shares at $1.39 ($14K) on 2023-03-21, disclosed to the SEC on 2023-03-22.
Open-market purchase of $14k CVKD by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| ORLY | SELL | 2025-05-20 | $276K | — | Filing → |
| ORLY | SELL | 2024-02-15 | $559K | — | Filing → |
| ORLY | SELL | 2023-11-02 | $465K | — | Filing → |